## Severe Malaria Diagnosis This patient meets WHO criteria for severe P. falciparum malaria: - **Parasitemia >5%** (8%) - **Cerebral involvement** (confusion) - **Acute respiratory distress** (RR 32/min → ARDS) - **Acute kidney injury** (creatinine 2.8 mg/dL) - **Jaundice** (hepatic dysfunction) ## Treatment Algorithm for Severe Malaria ```mermaid flowchart TD A[P. falciparum malaria confirmed]:::outcome --> B{Severity criteria present?}:::decision B -->|Yes: parasitemia >5%, cerebral/renal/respiratory involvement| C[Severe malaria]:::urgent B -->|No: uncomplicated| D[Oral artemisinin-based combination]:::action C --> E[IV artesunate 2.4 mg/kg at 0, 12, 24 hrs, then daily]:::action E --> F[ICU admission, supportive care]:::action F --> G[Monitor parasitemia, organ function]:::action G --> H{Parasitemia <1% and clinical improvement?}:::decision H -->|Yes| I[Switch to oral ACT to complete 3-day course]:::action H -->|No| J[Continue IV artesunate + management of complications]:::action ``` **Key Point:** IV artesunate is the gold standard for severe malaria globally, including in India. It reduces mortality by ~35% compared to quinine. **High-Yield:** Dosing: **2.4 mg/kg IV at 0, 12, and 24 hours, then once daily** until parasitemia <1% and patient can tolerate oral therapy. **Clinical Pearl:** Artesunate must be reconstituted with 5.3 mL of 0.9% sodium chloride (not water). Intravenous administration is superior to intramuscular in severe malaria. **Warning:** Quinine is inferior to artesunate and is no longer recommended as first-line for severe malaria, even though it was historically used. Do not delay artesunate initiation. ## Supportive Measures - ICU/high-dependency unit admission - Mechanical ventilation if ARDS worsens - Renal replacement therapy if creatinine rises further - Blood transfusion for severe anaemia - Correction of hypoglycaemia, electrolyte abnormalities - Anticonvulsants if seizures occur (cerebral malaria) **Note:** Exchange transfusion is rarely performed in modern practice; it is not standard of care and delays definitive antimalarial therapy.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.